IGC Pharma (IGC) EBITDA Margin Growth (3y) (2013 - 2025)
IGC Pharma (IGC) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
33,566.00 |
| Jun 30, 2025 |
92,857.00 |
| Mar 31, 2025 |
513,715.00 |
| Dec 31, 2024 |
90,386.00 |
| Sep 30, 2024 |
730,104.00 |
| Jun 30, 2024 |
155,840.00 |
| Mar 31, 2024 |
272,271.00 |
| Dec 31, 2023 |
-61,699.00 |
| Sep 30, 2023 |
34,808.00 |
| Jun 30, 2023 |
-4,006.00 |
| Mar 31, 2023 |
938,319.00 |
| Dec 31, 2022 |
-40,852.00 |
| Sep 30, 2022 |
-122,641.00 |
| Jun 30, 2022 |
-133,451.00 |
| Mar 31, 2022 |
-539,856.00 |
| Dec 31, 2021 |
-155,180.00 |
| Sep 30, 2021 |
-757,433.00 |
| Jun 30, 2021 |
-237,835.00 |
| Mar 31, 2021 |
-363,748.00 |
| Dec 31, 2020 |
-205,182.00 |
